These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30924322)

  • 1. Two de novo GJA1 mutation in two sporadic patients with erythrokeratodermia variabilis et progressiva.
    Li C; Liang J; Chen P; Zeng K; Xue R; Tian X; Liang L; Wang Q; Shi M; Zhang X
    Mol Genet Genomic Med; 2019 Jun; 7(6):e670. PubMed ID: 30924322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrogation of Carboxy-Terminus Localized
    Lucaciu SA; Shao Q; Figliuzzi R; Barr K; Bai D; Laird DW
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant De Novo Mutations in GJA1 Cause Erythrokeratodermia Variabilis et Progressiva, without Features of Oculodentodigital Dysplasia.
    Boyden LM; Craiglow BG; Zhou J; Hu R; Loring EC; Morel KD; Lauren CT; Lifton RP; Bilguvar K; Paller AS; Choate KA
    J Invest Dermatol; 2015 Jun; 135(6):1540-1547. PubMed ID: 25398053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrokeratodermia variabilis et progressiva due to a novel mutation in GJB4.
    Zhang X; Xu P; Lu J; Ding Y; Gu J; Shi Y
    Exp Dermatol; 2022 Apr; 31(4):594-599. PubMed ID: 34717022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrokeratodermia variabilis et progressiva allelic to oculo-dento-digital dysplasia.
    Duchatelet S; Hovnanian A
    J Invest Dermatol; 2015 Jun; 135(6):1475-1478. PubMed ID: 25964267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrokeratodermia variabilis et progressiva.
    Ishida-Yamamoto A
    J Dermatol; 2016 Mar; 43(3):280-5. PubMed ID: 26945536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical variability of the GJB4:c.35G > A gene variant: a study of a large Brazilian erythrokeratodermia pedigree.
    de Oliveira RTG; Christofolini DM; Criado PR; Lacaz Martins E; Kelsell D; Machado Filho CDS
    Int J Dermatol; 2020 Jun; 59(6):722-725. PubMed ID: 32311086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heterozygous mutation in GJA1 gene in Chinese family with serious erythrokeratodermia variabilis et progressive.
    Guo BR; Cai HB; Zong WK; Li CS; Liu LZ; Qiao S; Zhu QM; Li M
    Chin Med J (Engl); 2019 Jan; 132(1):86-88. PubMed ID: 30628963
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic heterogeneity in erythrokeratodermia variabilis: novel mutations in the connexin gene GJB4 (Cx30.3) and genotype-phenotype correlations.
    Richard G; Brown N; Rouan F; Van der Schroeff JG; Bijlsma E; Eichenfield LF; Sybert VP; Greer KE; Hogan P; Campanelli C; Compton JG; Bale SJ; DiGiovanna JJ; Uitto J
    J Invest Dermatol; 2003 Apr; 120(4):601-9. PubMed ID: 12648223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing identifies novel compound heterozygous mutations in GJB3 gene that cause erythrokeratodermia variabilis et progressiva.
    Deng Y; Wang H; Mou Y; Zeng Q; Xiong X
    Australas J Dermatol; 2019 Feb; 60(1):e87-e89. PubMed ID: 29992552
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel and recurrent connexin 30.3 and connexin 31 mutations associated with erythrokeratoderma variabilis.
    Scott CA; O'Toole EA; Mohungoo MJ; Messenger A; Kelsell DP
    Clin Exp Dermatol; 2011 Jan; 36(1):88-90. PubMed ID: 21188847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare missense mutation in GJB3 (Cx31G45E) is associated with a unique cellular phenotype resulting in necrotic cell death.
    Easton JA; Albuloushi AK; Kamps MAF; Brouns GHMR; Broers JLV; Coull BJ; Oji V; van Geel M; van Steensel MAM; Martin PE
    Exp Dermatol; 2019 Oct; 28(10):1106-1113. PubMed ID: 29570224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrokeratodermia variabilis: report of two cases and a novel missense variant in GJB4 encoding connexin 30.3.
    Kokotas H; Papagiannaki K; Grigoriadou M; Petersen MB; Katsarou A
    Eur J Dermatol; 2012; 22(2):182-6. PubMed ID: 22266302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrokeratoderma variabilis caused by a recessive mutation in GJB3.
    Fuchs-Telem D; Pessach Y; Mevorah B; Shirazi I; Sarig O; Sprecher E
    Clin Exp Dermatol; 2011 Jun; 36(4):406-11. PubMed ID: 21564177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrokeratodermia Variabilis-like Phenotype in Patients Carrying
    Hotz A; Fölster-Holst R; Oji V; Bourrat E; Frank J; Marrakchi S; Ennouri M; Wankner L; Komlosi K; Alter S; Fischer J
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and recurrent mutations in GJB3 and GJB4 cause erythrokeratodermia variabilis et progressiva.
    Dai S; Wang H; Lin Z
    Indian J Dermatol Venereol Leprol; 2020; 86(1):87-90. PubMed ID: 31793497
    [No Abstract]   [Full Text] [Related]  

  • 17. Expanding the clinical phenotype associated with NIPAL4 mutation: Study of a Tunisian consanguineous family with erythrokeratodermia variabilis-Like Autosomal Recessive Congenital Ichthyosis.
    Charfeddine C; Laroussi N; Mkaouar R; Jouini R; Khayat O; Redissi A; Mosbah A; Dallali H; Chedly Debbiche A; Zaouak A; Fenniche S; Abdelhak S; Hammami-Ghorbel H
    PLoS One; 2021; 16(10):e0258777. PubMed ID: 34669720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel GJB3 mutation p.Thr202Asn in the M4 transmembrane domain underlies erythrokeratodermia variabilis.
    Sugiura K; Arima M; Matsunaga K; Akiyama M
    Br J Dermatol; 2015 Jul; 173(1):309-11. PubMed ID: 25556823
    [No Abstract]   [Full Text] [Related]  

  • 19. Inflammatory Linear Verrucous Epidermal Nevus with a Postzygotic GJA1 Mutation Is a Mosaic Erythrokeratodermia Variabilis et Progressiva.
    Umegaki-Arao N; Sasaki T; Fujita H; Aoki S; Kameyama K; Amagai M; Seishima M; Kubo A
    J Invest Dermatol; 2017 Apr; 137(4):967-970. PubMed ID: 27890787
    [No Abstract]   [Full Text] [Related]  

  • 20. Digenic inheritance in autosomal recessive non-syndromic hearing loss cases carrying GJB2 heterozygote mutations: assessment of GJB4, GJA1, and GJC3.
    Kooshavar D; Tabatabaiefar MA; Farrokhi E; Abolhasani M; Noori-Daloii MR; Hashemzadeh-Chaleshtori M
    Int J Pediatr Otorhinolaryngol; 2013 Feb; 77(2):189-93. PubMed ID: 23141803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.